These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

89 related items for PubMed ID: 7773214

  • 1. Bone marrow transplant-associated thrombotic microangiopathy: a case series.
    Zeigler ZR, Shadduck RK, Nemunaitis J, Andrews DF, Rosenfeld CS.
    Bone Marrow Transplant; 1995 Feb; 15(2):247-53. PubMed ID: 7773214
    [Abstract] [Full Text] [Related]

  • 2. Apheresis in grade 4 bone marrow transplant associated thrombotic microangiopathy: a case series.
    Dua A, Zeigler ZR, Shadduck RK, Nath R, Andrews DF, Agha M.
    J Clin Apher; 1996 Feb; 11(4):176-84. PubMed ID: 8986863
    [Abstract] [Full Text] [Related]

  • 3. Pilot study of combined cryosupernatant and protein A immunoadsorption exchange in the treatment of grade 3-4 bone marrow transplant-associated thrombotic microangiopathy.
    Zeigler ZR, Shadduck RK, Nath R, Andrews DF.
    Bone Marrow Transplant; 1996 Jan; 17(1):81-6. PubMed ID: 8673060
    [Abstract] [Full Text] [Related]

  • 4. Plasma von Willebrand Factor Antigen (vWF:AG) and thrombomodulin (TM) levels in Adult Thrombotic Thrombocytopenic Purpura/Hemolytic Uremic Syndromes (TTP/HUS) and bone marrow transplant-associated thrombotic microangiopathy (BMT-TM).
    Zeigler ZR, Rosenfeld CS, Andrews DF, Nemunaitis J, Raymond JM, Shadduck RK, Kramer RE, Gryn JF, Rintels PB, Besa EC, George JN.
    Am J Hematol; 1996 Dec; 53(4):213-20. PubMed ID: 8948657
    [Abstract] [Full Text] [Related]

  • 5. Thrombotic microangiopathy following allogeneic bone marrow transplantation is associated with intensive graft-versus-host disease prophylaxis.
    Paquette RL, Tran L, Landaw EM.
    Bone Marrow Transplant; 1998 Aug; 22(4):351-7. PubMed ID: 9722070
    [Abstract] [Full Text] [Related]

  • 6. Thrombotic thrombocytopenic purpura-like syndromes following bone marrow transplantation: an analysis of associated conditions and clinical outcomes.
    Roy V, Rizvi MA, Vesely SK, George JN.
    Bone Marrow Transplant; 2001 Mar; 27(6):641-6. PubMed ID: 11319595
    [Abstract] [Full Text] [Related]

  • 7. Complete response in severe thrombotic microangiopathy post bone marrow transplantation (BMT-TM) after multiple plasmaphereses.
    Milone J, Napal J, Bordone J, Etchegoyen O, Morales V.
    Bone Marrow Transplant; 1998 Nov; 22(10):1019-21. PubMed ID: 9849701
    [Abstract] [Full Text] [Related]

  • 8. Allogeneic peripheral blood stem cell transplantation in patients with early-phase hematologic malignancy: a retrospective comparison of short-term outcome with bone marrow transplantation.
    Lemoli RM, Bandini G, Leopardi G, Rosti G, Bonini A, Fortuna A, Rondelli D, Mangianti S, Motta MR, Rizzi S, Tassi C, Cavo M, Remiddi C, Curti A, Conte R, Tura S.
    Haematologica; 1998 Jan; 83(1):48-55. PubMed ID: 9542323
    [Abstract] [Full Text] [Related]

  • 9. [Bone marrow transplantation-associated thrombotic microangiopathy manifested by visual disturbance].
    Nakai K, Tajima K, Kishimoto Y, Katsura K, Kawamura M, Yamamoto Y, Hanada M, Zen K, Amakawa R, Fujimoto M, Fukuhara S.
    Rinsho Ketsueki; 2000 Jan; 41(1):25-31. PubMed ID: 10695395
    [Abstract] [Full Text] [Related]

  • 10. Intestinal thrombotic microangiopathy after allogeneic bone marrow transplantation: a clinical imitator of acute enteric graft-versus-host disease.
    Nishida T, Hamaguchi M, Hirabayashi N, Haneda M, Terakura S, Atsuta Y, Imagama S, Kanie T, Murata M, Taji H, Suzuki R, Morishita Y, Kodera Y.
    Bone Marrow Transplant; 2004 Jun; 33(11):1143-50. PubMed ID: 15077133
    [Abstract] [Full Text] [Related]

  • 11. Role of splenic irradiation in patients with chronic myeloid leukemia undergoing allogeneic bone marrow transplantation.
    Jabro G, Koc Y, Boyle T, Schenkein DP, Ravalese J, Wazer D, Miller KB.
    Biol Blood Marrow Transplant; 1999 Jun; 5(3):173-9. PubMed ID: 10392963
    [Abstract] [Full Text] [Related]

  • 12. Coagulation abnormalities and thrombotic microangiopathy following bone marrow transplantation from HLA-matched unrelated donors in patients with hematological malignancies.
    Natazuka T, Kajimoto K, Ogawa R, Imoto S, Koizumi T, Nishimura R, Nakagawa T.
    Bone Marrow Transplant; 1998 Apr; 21(8):815-9. PubMed ID: 9603406
    [Abstract] [Full Text] [Related]

  • 13. Thrombotic microangiopathy following bone marrow transplantation.
    Pettitt AR, Clark RE.
    Bone Marrow Transplant; 1994 Oct; 14(4):495-504. PubMed ID: 7858524
    [Abstract] [Full Text] [Related]

  • 14. Lymphoproliferative disorders following allogeneic bone marrow transplantation: the Vancouver experience.
    Micallef IN, Chhanabhai M, Gascoyne RD, Shepherd JD, Fung HC, Nantel SH, Toze CL, Klingemann HG, Sutherland HJ, Hogge DE, Nevill TJ, Le A, Barnett MJ.
    Bone Marrow Transplant; 1998 Nov; 22(10):981-7. PubMed ID: 9849695
    [Abstract] [Full Text] [Related]

  • 15. Thrombotic thrombocytopenic purpura associated with FK506 following bone marrow transplantation.
    Gharpure VS, Devine SM, Holland HK, Geller RB, O'Toole K, Wingard JR.
    Bone Marrow Transplant; 1995 Nov; 16(5):715-6. PubMed ID: 8547871
    [Abstract] [Full Text] [Related]

  • 16. Long-term follow-up of allogeneic bone marrow transplantation in patients with poor prognosis non-Hodgkin's lymphoma.
    Bernard M, Dauriac C, Drénou B, Leberre C, Branger B, Fauchet R, Le Prisé PY, Lamy T.
    Bone Marrow Transplant; 1999 Feb; 23(4):329-33. PubMed ID: 10100576
    [Abstract] [Full Text] [Related]

  • 17. Thrombotic microangiopathy after allogeneic blood and marrow transplantation is associated with dose-intensive myeloablative conditioning regimens, unrelated donor, and methylprednisolone T-cell depletion.
    Hahn T, Alam AR, Lawrence D, Ford L, Baer MR, Bambach B, Bernstein ZP, Czuczman MS, Silva J, Slack JL, Wetzler M, Becker J, McCarthy PL.
    Transplantation; 2004 Nov 27; 78(10):1515-22. PubMed ID: 15599317
    [Abstract] [Full Text] [Related]

  • 18. The outcome of unrelated donor bone marrow transplantation in patients with hematologic malignancies using tacrolimus (FK506) and low dose methotrexate for graft-versus-host disease prophylaxis.
    Devine SM, Geller RB, Lin LB, Dix SP, Holland HK, Maurer D, O'Toole K, Keller J, Connaghan DG, Heffner LT, Hillyer CD, Rodey GE, Winton EF, Maher RM, Fitzsimmons WE, Wingard JR.
    Biol Blood Marrow Transplant; 1997 Apr 27; 3(1):25-33. PubMed ID: 9209738
    [Abstract] [Full Text] [Related]

  • 19. Plasminogen activator inhibitor (PAI-1) antigen levels in primary TTP and secondary TTP post-bone marrow transplantation.
    Anthony MT, Zeigler ZR, Lister J, Raymond JM, Shadduck RK, Kramer RE, Gryn JF, Rintels PB, Besa EC, George JN, Silver B, Joyce R, Bodensteiner D.
    Am J Hematol; 1998 Sep 27; 59(1):9-14. PubMed ID: 9723570
    [Abstract] [Full Text] [Related]

  • 20. Booster marrow or blood cells for graft failure after allogeneic bone marrow transplantation.
    Remberger M, Ringdén O, Ljungman P, Hägglund H, Winiarski J, Lönnqvist B, Aschan J.
    Bone Marrow Transplant; 1998 Jul 27; 22(1):73-8. PubMed ID: 9678799
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.